8 citations
,
October 2021 in “bioRxiv (Cold Spring Harbor Laboratory)” Healthcare workers with a positive COVID-19 test were more likely to report long-COVID symptoms.
7 citations
,
April 2024 in “International Journal of Dermatology” Alopecia areata greatly affects the quality of life for children and their families.
6 citations
,
January 2018 in “International Journal of Dermatology” Repigmentation patterns in vitiligo depend on melanocyte source, lesion status, and therapy choice.
4 citations
,
August 2023 in “Frontiers in Pediatrics” Most children with MIS-C showed significant improvement by 6 months.
4 citations
,
July 2020 in “Journal of proteomics” Hair protein composition is similar across different races and shapes.
4 citations
,
March 2020 in “BMC Research Notes” Skin tags in obese individuals may indicate higher cardiovascular risk.
2 citations
,
July 2025 in “Journal of Health Population and Nutrition” Improving diet may help manage sleep disorders.
2 citations
,
May 2023 in “JAAD Case Reports” The document concludes that early and accurate diagnosis of hair loss on the top of the scalp in Black men is important to distinguish CCCA from other types of hair loss.
2 citations
,
December 2021 in “Dermatology Online Journal” COVID-19 has increased hair loss, but many patients see regrowth within months.
Belimumab effectively controls SLE disease activity and reduces steroid use.
1 citations
,
April 2024 in “JAAD International” Adults with alopecia areata stick to their medication better than those with atopic dermatitis.
1 citations
,
January 2024 in “The Journal of Dermatology” Taxane-based chemotherapy causes more hair loss and skin changes in Asian breast cancer patients.
1 citations
,
September 2023 in “Acta dermato-venereologica” Certain genetic variants are linked to frontal fibrosing alopecia in Spanish patients.
1 citations
,
December 2022 in “Biomedicines” Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.
1 citations
,
December 2022 in “BMC Public Health” Long-term effects of COVID-19 can vary over time and are more likely in certain age and gender groups, while race, income, and education levels have little to no impact. Ongoing medical care is needed due to potential complications.
1 citations
,
March 2022 in “British Journal of Clinical Pharmacology” 5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.
1 citations
,
January 2019 in “Indian Journal of Dermatology, Venereology and Leprology”
May 2026 in “Frontiers in Pharmacology” Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.
May 2026 in “Mendeley Data” May 2026 in “Mendeley Data” April 2026 in “The Journal of Urology” Low-dose finasteride may increase erectile dysfunction risk over time.
April 2026 in “Mendeley Data” April 2026 in “Meditsinskiy sovet = Medical Council” Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.
A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.
April 2026 in “Journal of the American Academy of Dermatology” Oral 5-alpha-reductase inhibitors for hair loss don't increase heart risk.
March 2026 in “Journal of Epidemiology & Community Health” Long-COVID symptoms like fatigue, cognitive issues, and mobility problems can last 6-12 months but are less common after milder illness.
March 2026 in “Dermatology Online Journal” Androgenetic alopecia is linked to higher cholesterol in both sexes and obesity in women.
March 2026 in “Journal of the American Academy of Dermatology”
February 2026 in “Mendeley Data” Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.
February 2026 in “Journal of the American Academy of Dermatology” The combination of spironolactone and low-dose minoxidil is generally safe for treating hair loss in adult females, with mostly mild side effects.